Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 Aug 2024
Historique:
received: 07 03 2024
accepted: 14 08 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 26 8 2024
Statut: epublish

Résumé

Understanding how gene-environment interactions (GEIs) influence the circulating proteome could aid in biomarker discovery and validation. The presence of GEIs can be inferred from single nucleotide polymorphisms that associate with phenotypic variability - termed variance quantitative trait loci (vQTLs). Here, vQTL association studies are performed on plasma levels of 1463 proteins in 52,363 UK Biobank participants. A set of 677 independent vQTLs are identified across 568 proteins. They include 67 variants that lack conventional additive main effects on protein levels. Over 1100 GEIs are identified between 101 proteins and 153 environmental exposures. GEI analyses uncover possible mechanisms that explain why 13/67 vQTL-only sites lack corresponding main effects. Additional analyses also highlight how age, sex, epistatic interactions and statistical artefacts may underscore associations between genetic variation and variance heterogeneity. This study establishes the most comprehensive database yet of vQTLs and GEIs for the human proteome.

Identifiants

pubmed: 39187491
doi: 10.1038/s41467-024-51744-5
pii: 10.1038/s41467-024-51744-5
doi:

Substances chimiques

Proteome 0
Blood Proteins 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7346

Subventions

Organisme : British Heart Foundation (BHF)
ID : FS/IPBSRF/22/27042
Organisme : Wellcome Trust (Wellcome)
ID : 108890/Z/15/Z
Organisme : Alzheimer's Society
ID : AS-PG-19b-010

Investigateurs

Eric Marshall (E)

Informations de copyright

© 2024. The Author(s).

Références

Geyer, P. E., Holdt, L. M., Teupser, D. & Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942 (2017).
pubmed: 28951502 pmcid: 5615924 doi: 10.15252/msb.20156297
Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat. Commun. 8, 14357 (2017).
pubmed: 28240269 pmcid: 5333359 doi: 10.1038/ncomms14357
Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73–79 (2018).
pubmed: 29875488 pmcid: 6697541 doi: 10.1038/s41586-018-0175-2
Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet 53, 1712–1721 (2021).
pubmed: 34857953 doi: 10.1038/s41588-021-00978-w
Yao, C. et al. Genome‐wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nat. Commun. 9, 3268 (2018).
pubmed: 30111768 pmcid: 6093935 doi: 10.1038/s41467-018-05512-x
Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329–338 (2023).
pubmed: 37794186 pmcid: 10567551 doi: 10.1038/s41586-023-06592-6
Zheng, J. et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat. Genet. 52, 1122–1131 (2020).
pubmed: 32895551 pmcid: 7610464 doi: 10.1038/s41588-020-0682-6
Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet 47, 856–860 (2015).
pubmed: 26121088 doi: 10.1038/ng.3314
King, E. A., Davis, J. W. & Degner, J. F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet 15, e1008489 (2019).
pubmed: 31830040 pmcid: 6907751 doi: 10.1371/journal.pgen.1008489
Lynch, M. & Walsh, B. Genetics and analysis of quantitative traits. (Sinauer, Sunderland, MA, 1998).
Garrod, A. The incidence of alkaptonuria: a study in chemical individuality. Lancet 160, 1616–1620 (1902).
doi: 10.1016/S0140-6736(01)41972-6
Kraft, P. & Hunter, D. Integrating epidemiology and genetic association: the challenge of gene–environment interaction. Philos. Trans. R. Soc. B: Biol. Sci. 360, 1609–1616 (2005).
doi: 10.1098/rstb.2005.1692
McAllister, K. et al. Current challenges and new opportunities for gene-environment interaction studies of complex diseases. Am. J. Epidemiol. 186, 753–761 (2017).
pubmed: 28978193 pmcid: 5860428 doi: 10.1093/aje/kwx227
Paré, G., Cook, N. R., Ridker, P. M. & Chasman, D. I. On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women’s Genome Health Study. PLoS Genet. 6, e1000981 (2010).
pubmed: 20585554 pmcid: 2887471 doi: 10.1371/journal.pgen.1000981
Wang, H. et al. Genotype-by-environment interactions inferred from genetic effects on phenotypic variability in the UK Biobank. Sci. Adv. 5, eaaw3538 (2019).
pubmed: 31453325 pmcid: 6693916 doi: 10.1126/sciadv.aaw3538
Marderstein, A. R. et al. Leveraging phenotypic variability to identify genetic interactions in human phenotypes. Am. J. Hum. Genet 108, 49–67 (2021).
pubmed: 33326753 doi: 10.1016/j.ajhg.2020.11.016
Westerman, K. E. et al. Variance-quantitative trait loci enable systematic discovery of gene-environment interactions for cardiometabolic serum biomarkers. Nat. Commun. 13, 3993 (2022).
pubmed: 35810165 pmcid: 9271055 doi: 10.1038/s41467-022-31625-5
Shi, G. Genome-wide variance quantitative trait locus analysis suggests small interaction effects in blood pressure traits. Sci. Rep. 12, 12649 (2022).
pubmed: 35879408 pmcid: 9314370 doi: 10.1038/s41598-022-16908-7
Yang, J. et al. FTO genotype is associated with phenotypic variability of body mass index. Nature490, 267–272 (2012).
pubmed: 22982992 pmcid: 3564953 doi: 10.1038/nature11401
Chen, Z., Boehnke, M., Wen, X. & Mukherjee, B. Revisiting the genome-wide significance threshold for common variant GWAS. G3 (Bethesda) 11, jkaa056 (2021).
Ghoussaini, M. et al. Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res 49, D1311–d1320 (2021).
pubmed: 33045747 doi: 10.1093/nar/gkaa840
Mountjoy, E. et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat. Genet 53, 1527–1533 (2021).
pubmed: 34711957 pmcid: 7611956 doi: 10.1038/s41588-021-00945-5
Brown, A. A. et al. Genetic interactions affecting human gene expression identified by variance association mapping. Elife 3, e01381 (2014).
pubmed: 24771767 pmcid: 4017648 doi: 10.7554/eLife.01381
Ek, W. E. et al. Genetic variants influencing phenotypic variance heterogeneity. Hum. Mol. Genet 27, 799–810 (2018).
pubmed: 29325024 doi: 10.1093/hmg/ddx441
Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47, D1005–d1012 (2019).
pubmed: 30445434 doi: 10.1093/nar/gky1120
Mayne, J. et al. Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function. J. Clin. Endocrinol. Metab. 103, 3486–3495 (2018).
pubmed: 29982529 doi: 10.1210/jc.2018-00777
Del Giudice, M. & Gangestad, S. W. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav. Immun. 70, 61–75 (2018).
pubmed: 29499302 doi: 10.1016/j.bbi.2018.02.013
Gao, S. et al. Oxytocin, the peptide that bonds the sexes also divides them. Proc. Natl Acad. Sci. USA 113, 7650–7654 (2016).
pubmed: 27325780 pmcid: 4941426 doi: 10.1073/pnas.1602620113
Kim, S. W. et al. Flt3 ligand induces monocyte proliferation and enhances the function of monocyte-derived dendritic cells in vitro. J. Cell Physiol. 230, 1740–1749 (2015).
pubmed: 25215878 doi: 10.1002/jcp.24824
Cao, Y., Wei, P., Bailey, M., Kauwe, J. S. K. & Maxwell, T. J. A versatile omnibus test for detecting mean and variance heterogeneity. Genet Epidemiol. 38, 51–59 (2014).
pubmed: 24482837 pmcid: 4019404 doi: 10.1002/gepi.21778
Young, A. I., Wauthier, F. L. & Donnelly, P. Identifying loci affecting trait variability and detecting interactions in genome-wide association studies. Nat. Genet 50, 1608–1614 (2018).
pubmed: 30323177 doi: 10.1038/s41588-018-0225-6
Milne, P. et al. Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Blood Adv. 3, 3052–3061 (2019).
pubmed: 31648336 pmcid: 6849950 doi: 10.1182/bloodadvances.2019000197
Seppälä, M., Taylor, R. N., Koistinen, H., Koistinen, R. & Milgrom, E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr. Rev. 23, 401–430 (2002).
pubmed: 12202458 doi: 10.1210/er.2001-0026
Li, T. C., Dalton, C., Hunjan, K. S., Warren, M. A. & Bolton, A. E. The correlation of placental protein 14 concentrations in uterine flushing and endometrial morphology in the peri-implantation period. Hum. Reprod. 8, 1923–1927 (1993).
pubmed: 8288761 doi: 10.1093/oxfordjournals.humrep.a137961
Riittinen, L., Julkunen, M., Seppälä, M., Koistinen, R. & Huhtala, M. L. Purification and characterization of endometrial protein PP14 from mid-trimester amniotic fluid. Clin. Chim. Acta 184, 19–29 (1989).
pubmed: 2688994 doi: 10.1016/0009-8981(89)90253-2
Chiu, P. C. et al. Cumulus oophorus-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. J. Biol. Chem. 282, 5378–5388 (2007).
pubmed: 17192260 doi: 10.1074/jbc.M607482200
Koistinen, H. et al. Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol. Hum. Reprod. 2, 759–765 (1996).
pubmed: 9239694 doi: 10.1093/molehr/2.10.759
Julkunen, M. et al. Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract. Arch. Androl. 12, 59–67 (1984).
pubmed: 6398989
Uchida, H. et al. Glycodelin in reproduction. Reprod. Med Biol. 12, 79–84 (2013).
pubmed: 29699134 pmcid: 5904763 doi: 10.1007/s12522-013-0144-2
Seppälä, M., Rönnberg, L., Karonen, S. L. & Kauppila, A. Micronized oral progesterone increases the circulating level of endometrial secretory PP14/beta-lactoglobulin homologue. Hum. Reprod. 2, 453–455 (1987).
pubmed: 3312283 doi: 10.1093/oxfordjournals.humrep.a136569
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Wik, L. et al. Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis. Mol. Cell Proteom. 20, 100168 (2021).
doi: 10.1016/j.mcpro.2021.100168
Kretzschmar, W., Mahajan, A., Sharp, K., McCarthy, M. & Consortium, H. R. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genetics 48 (2016).
Walter, K. et al. The UK10K project identifies rare variants in health and disease. Nature 526, 82–90 (2015). Management committee.
pubmed: 26367797 doi: 10.1038/nature14962
Kuhn, R. M., Haussler, D. & Kent, W. J. The UCSC genome browser and associated tools. Brief. Bioinform 14, 144–161 (2013).
pubmed: 22908213 doi: 10.1093/bib/bbs038
Zhang, F. et al. OSCA: a tool for omic-data-based complex trait analysis. Genome Biol. 20, 1–13 (2019).
doi: 10.1186/s13059-019-1718-z
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Chubukov, V., Gerosa, L., Kochanowski, K. & Sauer, U. Coordination of microbial metabolism. Nat. Rev. Microbiol. 12, 327–340 (2014).
pubmed: 24658329 doi: 10.1038/nrmicro3238
Piazza, I. et al. A map of protein-metabolite interactions reveals principles of chemical communication. Cell 172, 358–372.e23 (2018).
pubmed: 29307493 doi: 10.1016/j.cell.2017.12.006
Keller, M. C. Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol. Psychiatry 75, 18–24 (2014).
pubmed: 24135711 doi: 10.1016/j.biopsych.2013.09.006
Hillary, R. F., et al. Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank. Zenodo https://doi.org/10.5281/zenodo.11246859 (2024).

Auteurs

Robert F Hillary (RF)

Optima Partners, Edinburgh, EH2 4HQ, UK.
Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.

Danni A Gadd (DA)

Optima Partners, Edinburgh, EH2 4HQ, UK.
Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.

Zhana Kuncheva (Z)

Optima Partners, Edinburgh, EH2 4HQ, UK.
Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.
Bayes Centre, The University of Edinburgh, Edinburgh, EH8 9BT, UK.

Tasos Mangelis (T)

Optima Partners, Edinburgh, EH2 4HQ, UK.
Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.
Bayes Centre, The University of Edinburgh, Edinburgh, EH8 9BT, UK.

Tinchi Lin (T)

Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.

Kyle Ferber (K)

Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.

Helen McLaughlin (H)

Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.

Heiko Runz (H)

Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA.

Riccardo E Marioni (RE)

Optima Partners, Edinburgh, EH2 4HQ, UK. riccardo.marioni@ed.ac.uk.
Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK. riccardo.marioni@ed.ac.uk.
Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA. riccardo.marioni@ed.ac.uk.

Christopher N Foley (CN)

Optima Partners, Edinburgh, EH2 4HQ, UK. chris.foley@optimapartners.co.uk.
Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA. chris.foley@optimapartners.co.uk.
Bayes Centre, The University of Edinburgh, Edinburgh, EH8 9BT, UK. chris.foley@optimapartners.co.uk.

Benjamin B Sun (BB)

Translational Sciences, Research and Development, Biogen Inc., Cambridge, MA, USA. bbsun92@outlook.com.
Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK. bbsun92@outlook.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH